Understanding how genetics and aging affect cancer risk and treatment.
Genetics, Epigenetics and Metabolism Research Program
['FUNDING_P30'] · UNIVERSITY OF ROCHESTER · NIH-11014529
This study is looking at how our genes and the way they change over time can affect aging and cancer, with the goal of finding better ways to prevent and treat cancer, so patients like you can have more options for care.
Quick facts
| Phase | ['FUNDING_P30'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ROCHESTER (nih funded) |
| Locations | 1 site (ROCHESTER, UNITED STATES) |
| Trial ID | NIH-11014529 on ClinicalTrials.gov |
What this research studies
The Genetics, Epigenetics and Metabolism (GEM) program investigates the complex interactions between genetic and epigenetic factors that contribute to aging and cancer. By studying how aging influences cellular changes and vulnerabilities, researchers aim to uncover new therapeutic strategies for cancer treatment. The program involves collaboration among experts from various fields, fostering innovative approaches to understanding cancer biology. Patients may benefit from insights gained through this research, which could lead to improved cancer prevention and treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for cancer due to age or genetic predispositions.
Not a fit: Patients with no genetic or age-related risk factors for cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing and treating cancer by targeting the mechanisms of aging.
How similar studies have performed: Previous research has shown promising results in understanding the links between aging and cancer, indicating that this approach has potential for significant breakthroughs.
Where this research is happening
ROCHESTER, UNITED STATES
- UNIVERSITY OF ROCHESTER — ROCHESTER, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VERTINO, PAULA M. — UNIVERSITY OF ROCHESTER
- Study coordinator: VERTINO, PAULA M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.